{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T03:43:49Z","timestamp":1766720629626},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1245\/s10434-016-5704-3","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T20:36:38Z","timestamp":1482179798000},"page":"1330-1335","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer"],"prefix":"10.1245","volume":"24","author":[{"given":"Heriberto","family":"Medina-Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Cort\u00e9s-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lambreton-Hinojosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Fimbres-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Carlos","family":"Vargas-Siordia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"5704_CR1","unstructured":"International Agency for Research on Cancer; World Health Organization; GLOBOCAN 2012. Fact sheets by population. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_population.aspx ."},{"key":"5704_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.21149\/spm.v56i5.7373","volume":"56","author":"LE Torres-S\u00e1nchez","year":"2014","unstructured":"Torres-S\u00e1nchez LE, Rojas-Mart\u00ednez R, Escamilla-N\u00fa\u00f1ez C, Vara-Salazar E de, Lazcano-Ponce E. Tendencias en la mortalidad por c\u00e1ncer en M\u00e9xico de 1980 a 2011. Salud Publica Mex. 2014;56:473\u201391.","journal-title":"Salud Publica Mex."},{"key":"5704_CR3","unstructured":"Surveillance, Epidemiology, and End Results. SEER Stat Fact Sheets: soft tissue including heart cancer. Statistics at a glance. 2015. https:\/\/seer.cancer.gov\/faststats\/selections.php?series=cancer ."},{"key":"5704_CR4","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519\u201329.","journal-title":"N Engl J Med."},{"key":"5704_CR5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","volume":"103","author":"RE Bristow","year":"2006","unstructured":"Bristow RE, Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol. 2006;103:1070\u20136.","journal-title":"Gynecol Oncol."},{"key":"5704_CR6","first-page":"847","volume":"20","author":"U Solmaz","year":"2015","unstructured":"Solmaz U, Mat E, Dereli ML, et al. Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone? J Buon. 2015;20:847\u201354.","journal-title":"J Buon."},{"key":"5704_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2006.11.025","volume":"105","author":"JY Hou","year":"2007","unstructured":"Hou JY, Kelly MG, Yu H, et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol. 2007;105:211\u201317.","journal-title":"Gynecol Oncol."},{"key":"5704_CR8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943\u201353.","journal-title":"N Engl J Med."},{"key":"5704_CR9","unstructured":"Gallardo-Rinc\u00f3n D, CXant\u00fa-de Le\u00f3n D, Alan\u00eds-L\u00f3pez P, et al. Third national ovarian consensus. Rev Invest Clin. 2011;63:665\u2013702."},{"key":"5704_CR10","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMe048292","volume":"351","author":"T Thigpen","year":"2004","unstructured":"Thigpen T. The if and when of surgical debulking for ovarian carcinoma. N Engl J Med. 2004;351:2544\u20136.","journal-title":"N Engl J Med."},{"key":"5704_CR11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2006.11.002","volume":"104","author":"RE Bristow","year":"2007","unstructured":"Bristow RE, Eisenhauer EL, Santillan A, Chi DS. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol. 2007;104:480\u201390.","journal-title":"Gynecol Oncol."},{"key":"5704_CR12","first-page":"2315","volume":"35","author":"N Bacalbasa","year":"2015","unstructured":"Bacalbasa N, Balescu I, Dima S, et al. Initial incomplete surgery modifies prognosis in advanced ovarian cancer regardless of subsequent management. Anticancer Res. 2015;35:2315\u201320.","journal-title":"Anticancer Res."},{"key":"5704_CR13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","volume":"351","author":"P Rose","year":"2004","unstructured":"Rose P, Nerenstone S, Brady M, et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Eng J Med. 2004;351:2489\u201397.","journal-title":"N Eng J Med."},{"key":"5704_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajco.12449","volume":"11","author":"J Goh","year":"2015","unstructured":"Goh J, Mohan GR, Ladwa R, Ananda S, Cohen PA, Baron-hay S. Frontline treatment of epithelial ovarian cancer. Asia Pac J Clin Oncol. 2015;11:1\u201316.","journal-title":"Asia Pac J Clin Oncol."},{"key":"5704_CR15","doi-asserted-by":"crossref","unstructured":"Markauskas A, Mogensen O, dePont Christensen R, Jensen PT. Primary surgery or interval debulking for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2014;24:1420\u20138.","DOI":"10.1097\/IGC.0000000000000241"},{"key":"5704_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-6-153","volume":"6","author":"A Inciura","year":"2006","unstructured":"Inciura A, Simavicius A, Juozaityte E, et al. Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients. BMC Cancer. 2006;6:153","journal-title":"BMC Cancer."},{"key":"5704_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2407-9-171","volume":"9","author":"JL Brun","year":"2009","unstructured":"Brun JL, Rouzier R, Selle F, Houry S, Uzan S, Dara\u00ef E. Neoadjuvant chemotherapy or primary surgery for stage III\/IV ovarian cancer: contribution of diagnostic laparoscopy. BMC Cancer. 2009;9:171.","journal-title":"BMC Cancer."},{"key":"5704_CR18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00404-013-2924-7","volume":"288","author":"S Ta\u015fk\u0131n","year":"2013","unstructured":"Ta\u015fk\u0131n S, G\u00fcng\u00f6r M, Orta\u00e7 F, \u00d6ztuna D. Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer. Arch Gynecol Obstet. 2013;288:1399\u2013403.","journal-title":"Arch Gynecol Obstet."},{"key":"5704_CR19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","volume":"22","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E. Cytoreductive surgery and hipec in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015;22:1570\u20135.","journal-title":"Ann Surg Oncol."},{"key":"5704_CR20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1245\/s10434-014-4049-z","volume":"22","author":"PA Cascales-Campos","year":"2015","unstructured":"Cascales-Campos PA, Gil J, Feliciangeli E, et al. The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction. Ann Surg Oncol. 2015;22:987\u201393.","journal-title":"Ann Surg Oncol."},{"key":"5704_CR21","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1245\/s10434-012-2510-4","volume":"19","author":"N Bakrin","year":"2012","unstructured":"Bakrin N, Cotte E, Golfier F, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients. Ann Surg Oncol. 2012;19:4052\u20138.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5704-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5704-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5704-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:16:27Z","timestamp":1498371387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5704-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["5704"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5704-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]}}}